R. Erik Holmlin
CIK 1579988 · PRESIDENT AND CEO · last filed 2026-02-18
R. Erik Holmlin is a PRESIDENT AND CEO who has filed 23 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing shows the insider had shares withheld for taxes covering $56 of BNGO on Feb 18, 2026. Across all open-market trades the lifetime net is +$39.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BNGOW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NORTHBROOK, IL 60062
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BNGO | PRESIDENT AND CEO | 1,665 | $1.25 | $2.1K | $0 | 7 | 2026-02-18 |
| Bionano Genomics, Inc. (BNGOW) Delisted | President and CEO | 811,499 | $0.00 | $2.9K | $29.7K | 11 | 2023-05-16 |
| Bionano Genomics, Inc. (BNGOU) Delisted | President and CEO | 1,630 | — | — | $10.0K | 1 | 2018-08-27 |
| NANOSPHERE INC (NSPH) Delisted | Director | — | — | — | $0 | 1 | 2013-06-24 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-18 | BNGO | Tax (F) | −51 | -$56 | EDGAR |
| 2026-02-04 | BNGO | Grant (A) | — | $0 | EDGAR |
| 2025-06-03 | BNGO | Tax (F) | −75 | -$277 | EDGAR |
| 2025-03-18 | BNGO | Mixed | −198 | -$687 | EDGAR |
| 2025-02-19 | BNGO | Tax (F) | −51 | -$292 | EDGAR |
| 2024-06-05 | BNGO | Grant (A) | +44,000 | $0 | EDGAR |
| 2024-03-05 | BNGO | Tax (F) | −3,073 | -$3.9K | EDGAR |
| 2023-05-16 | Bionano Genomics, Inc. (BNGOW) Delisted | Buy (P) | +15,000 | $9.6K | EDGAR |
| 2023-05-16 | Bionano Genomics, Inc. (BNGOW) Delisted | Tax (F) | −50,141 | -$33.1K | EDGAR |
| 2023-02-17 | Bionano Genomics, Inc. (BNGOW) Delisted | Grant (A) | +300,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.